Skip to content

Insight, China's Pharmaceutical Industry

Fineline Insights, Pharma Clarity

  • Home
  • About US
  • Bioinsight
  • Policy Hub
  • Deals Book
  • Privacy Policy
  • Contact US

Header Toggle Sidebar

This is an example widget to show how the Header Toggle Sidebar looks by default. You can add custom widgets from the widgets in the admin.

Company Deals

QL Biopharma Raises 500M+ RMB Series C – OrbiMed Leads Round for Monthly GLP‑1 Zovigrutide

Fineline Cube Mar 2, 2026
Company Deals

Tonghua Dongbao Partners with Huisheng Biopharma – Secures China Rights to First Domestic Insulin Degludec Biosimilars

Fineline Cube Feb 27, 2026
Company Deals Drug

Jumpcan Pharma Secures China Rights to Thederma’s TAP-1503 – First AhR Modulator for Atopic Dermatitis

Fineline Cube Feb 27, 2026
Company Deals

WuXi XDC Licenses WuXiTecan-2 Technology to Earendil Labs – $885M Deal Powers AI‑Driven ADC Development

Fineline Cube Feb 27, 2026
Company Deals

SteinCares Partners with Shilpa Biologicals on Latin America Biosimilar Deal – Regional Commercialization Agreement

Fineline Cube Feb 26, 2026
Policy / Regulatory

NMPA CDE Launches “Caring Program – Extension” Pilot – Accelerates Rare Disease Drug Development Pathway

Fineline Cube Mar 2, 2026
Company Drug

Lynk Pharma’s Zemprocitinib Hits Phase III Endpoints in Atopic Dermatitis – Best‑in‑Class JAK1 Inhibitor Shows Superior Efficacy

Fineline Cube Mar 2, 2026
Company Drug

HealZen’s BTK Inhibitor HZ-A-018 Wins NMPA Approval for CSU Phase II – Expands Autoimmune Pipeline

Fineline Cube Mar 2, 2026
Company Deals

Bosscome Science & Technology Secures Series A Funding for Precision Medical Navigation Systems

Fineline Cube Nov 30, 2023

Bosscome Science & Technology, a Chongqing-based developer of integrated optical and magnetic navigation systems, has...

Company Policy / Regulatory

NMPA Approves TINGSN Technology’s Disposable Intracardiac Ultrasound Diagnostic Catheter

Fineline Cube Nov 30, 2023

The National Medical Products Administration (NMPA) has granted market approval to TINGSN Technology, a China-based...

Company Drug

Everest Medicines’ Nefecon NDA for IgAN Accepted for Review in South Korea

Fineline Cube Nov 30, 2023

Everest Medicines (HKG: 1952), a China-based pharmaceutical company, has announced that the New Drug Application...

Company Digital

ClouDr Partners with Yangtze River Pharmaceutical to Digitize Chronic Disease Marketing

Fineline Cube Nov 30, 2023

Hangzhou Kang Ming Information Technology Co., Ltd, trading as “ClouDr” (HKG: 9955), has entered into...

Company Policy / Regulatory

CAR T-Cell Therapy Stocks Plunge as FDA Investigates Cancer Reports Linked to Treatments

Fineline Cube Nov 30, 2023

Shares of Chimeric Antigen Receptor (CAR) T cell therapy companies plummeted on November 28, 2023,...

Company Deals

Pfizer Enters Strategic Alliance with Guangdong Government to Boost Biomedicine R&D

Fineline Cube Nov 29, 2023

Pfizer (NYSE: PFE), the US pharmaceutical powerhouse, has signed a strategic memorandum of understanding with...

Company Deals

Bayer Partners with Hurdle to Launch Saliva-Based Age Tests in Global E-Commerce

Fineline Cube Nov 29, 2023

Bayer (ETR: BAYN), the German multinational, has announced a strategic collaboration to globally distribute Hurdle’s...

Company Drug

Merck’s V116 Pneumococcal Vaccine Shows Promising Data Against Pfizer’s Prevnar 20

Fineline Cube Nov 29, 2023

Merck, Sharp & Dohme (MSD; NYSE: MRK) has unveiled new data from a late-stage trial...

Policy / Regulatory

China’s Pharma Distribution Market Grows Steadily in 2022, Driven by Retail Sales Surge

Fineline Cube Nov 29, 2023

The Ministry of Commerce (MofCOM) has released its annual statistical review of China’s pharmaceutical distribution...

Company Deals

BMS and Avidity Biosciences Join Forces on $2.2 Billion Cardiology Antibody Oligonucleotide Conjugate Deal

Fineline Cube Nov 29, 2023

Bristol Myers Squibb (BMS, NYSE: BMY) has announced a strategic partnership with Avidity Biosciences (NASDAQ:...

Company Deals

Blue Sail Medical and China National Medical Device Forge Strategic Partnership for Growth

Fineline Cube Nov 29, 2023

Blue Sail Medical Co., Ltd (SHE: 002382), a prominent player in China’s medical device sector,...

Company

Alibaba Health Reports 12.7% Revenue Growth in H1 2023, Driven by Pharmaceutical and Digital Services

Fineline Cube Nov 29, 2023

Alibaba Health Information Technology Ltd (HKG: 0241), based in China, has released its financial results...

Company Drug

JW Therapeutics Secures Priority Review for Carteyva in Relapsed/Refractory Mantle Cell Lymphoma

Fineline Cube Nov 29, 2023

JW Therapeutics (HKG: 2126), based in China, has announced that its CAR-T cell therapy, Carteyva...

Company Drug

Beijing Konruns Pharmaceutical Launches Phase III Study for KC1036 in Advanced Esophageal Cancer

Fineline Cube Nov 29, 2023

Beijing Konruns Pharmaceutical Co., Ltd (SHA: 603590), based in Beijing, has received approval from China’s...

Company Drug

Lee’s Pharmaceutical Secures NMPA Approval for Adasuve, Pioneering Loxapine Inhaler for Agitation

Fineline Cube Nov 29, 2023

Lee’s Pharmaceutical Holdings Ltd (HKG: 0950) has secured marketing approval from China’s National Medical Products...

Company Medical Device

AK Medical Holdings Receives NMPA Approval for Hip Surgery Navigation System iBot

Fineline Cube Nov 29, 2023

AK Medical Holdings Ltd (HKG: 1789), a Chinese medical technology company, has announced that it...

Company Drug

Gracell Biotechnologies Gets FDA Green Light for FasTCAR-T Therapy in Systemic Lupus Erythematosus

Fineline Cube Nov 29, 2023

Gracell Biotechnologies Inc., a Suzhou-based biotech company (NASDAQ: GRCL), has received approval from the US...

Company Deals

Mabwell Bioscience Enters Thai Market with Licensing Deal with Innobic

Fineline Cube Nov 29, 2023

Mabwell (Shanghai) Bioscience Co., Ltd (SHA: 688062), a Chinese biopharmaceutical company, has announced the signing...

Company Deals

Taihe Weiye Biotechnology Secures RMB 300 Million in Series A+ Financing to Expand Production

Fineline Cube Nov 29, 2023

Chengdu Taihe Weiye Biotechnology Co., Ltd, a Chinese developer of protected amino acids drugs, has...

Company Drug

Dupixent Trial Success Reinforces Potential in Moderate-to-Severe COPD Treatment

Fineline Cube Nov 28, 2023

Regeneron Pharmaceuticals (NASDAQ: REGN) and Sanofi (NASDAQ: SNY) have announced that a late-stage replicate trial...

Posts pagination

1 … 399 400 401 … 628

Recent updates

  • Lynk Pharma’s Zemprocitinib Hits Phase III Endpoints in Atopic Dermatitis – Best‑in‑Class JAK1 Inhibitor Shows Superior Efficacy
  • HealZen’s BTK Inhibitor HZ-A-018 Wins NMPA Approval for CSU Phase II – Expands Autoimmune Pipeline
  • Ribo Life Science’s PCSK9 siRNA RBD7022 Enters Phase III – Qilu Pharma Advances Cholesterol‑Lowering Drug
  • GenFleet’s GFH375 Wins CDE Breakthrough Therapy Designation – Oral KRAS G12D Inhibitor for NSCLC
  • InnoCare’s Zurletrectinib Wins Priority Review for Pediatric NTRK Tumors – Next‑Gen TRK Inhibitor Expands Label
Special Report 2025 Q1: U.S. Targets Chinese Pharma with 200% Tariffs—Will the Global Drug Market Collapse?

Category

  • Company
  • Deals
  • Digital
  • Drug
  • General/Other
  • Hospital
  • Legal / IP
  • Medical Device
  • Others
  • Policy / Regulatory
  • R&D

You Missed

Company Drug

Lynk Pharma’s Zemprocitinib Hits Phase III Endpoints in Atopic Dermatitis – Best‑in‑Class JAK1 Inhibitor Shows Superior Efficacy

Company Drug

HealZen’s BTK Inhibitor HZ-A-018 Wins NMPA Approval for CSU Phase II – Expands Autoimmune Pipeline

Company Drug

Ribo Life Science’s PCSK9 siRNA RBD7022 Enters Phase III – Qilu Pharma Advances Cholesterol‑Lowering Drug

Company Drug

GenFleet’s GFH375 Wins CDE Breakthrough Therapy Designation – Oral KRAS G12D Inhibitor for NSCLC

Insight, China's Pharmaceutical Industry

Fineline Insights, Pharma Clarity

Copyright © 2025 | Fineline Information & Technology | BlogData by Themeansar.